Tags

Type your tag names separated by a space and hit enter

The Use of Systemic and Topical Fluoroquinolones.
Pediatrics. 2016 11; 138(5)Ped

Abstract

Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children has become better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Prescribing clinicians should be aware of specific adverse reactions associated with fluoroquinolones, and their use in children should continue to be limited to the treatment of infections for which no safe and effective alternative exists or in situations in which oral fluoroquinolone treatment represents a reasonable alternative to parenteral antimicrobial therapy.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

27940800

Citation

Jackson, Mary Anne, et al. "The Use of Systemic and Topical Fluoroquinolones." Pediatrics, vol. 138, no. 5, 2016.
Jackson MA, Schutze GE, COMMITTEE ON INFECTIOUS DISEASES. The Use of Systemic and Topical Fluoroquinolones. Pediatrics. 2016;138(5).
Jackson, M. A., & Schutze, G. E. (2016). The Use of Systemic and Topical Fluoroquinolones. Pediatrics, 138(5).
Jackson MA, Schutze GE, COMMITTEE ON INFECTIOUS DISEASES. The Use of Systemic and Topical Fluoroquinolones. Pediatrics. 2016;138(5) PubMed PMID: 27940800.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Use of Systemic and Topical Fluoroquinolones. AU - Jackson,Mary Anne, AU - Schutze,Gordon E, AU - ,, PY - 2016/12/13/entrez PY - 2016/12/13/pubmed PY - 2017/6/27/medline JF - Pediatrics JO - Pediatrics VL - 138 IS - 5 N2 - Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children has become better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Prescribing clinicians should be aware of specific adverse reactions associated with fluoroquinolones, and their use in children should continue to be limited to the treatment of infections for which no safe and effective alternative exists or in situations in which oral fluoroquinolone treatment represents a reasonable alternative to parenteral antimicrobial therapy. SN - 1098-4275 UR - https://www.unboundmedicine.com/medline/citation/27940800/The_Use_of_Systemic_and_Topical_Fluoroquinolones_ L2 - http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=27940800 DB - PRIME DP - Unbound Medicine ER -